Free fatty acids enhance breast cancer cell migration through plasminogen activator inhibitor-1 and SMAD4

被引:44
|
作者
Byon, Chang Hyun [2 ]
Hardy, Robert W. [1 ]
Ren, Changchun [1 ]
Ponnazhagan, Selvarangan [1 ]
Welch, Danny R. [1 ,2 ]
McDonald, Jay M. [1 ,3 ]
Chen, Yabing [1 ]
机构
[1] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA
[2] Univ Alabama Birmingham, Dept Cell Biol, Birmingham, AL 35294 USA
[3] Vet Adm Med Ctr, Birmingham, AL USA
关键词
free fatty acids; breast cancer cell; migration; PAI-1; SMAD4; IN-VITRO; LINOLEIC-ACID; GROWTH; GENE; OBESITY; EXPRESSION; INVASION; IDENTIFICATION; METASTASIS; OVERWEIGHT;
D O I
10.1038/labinvest.2009.97
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Obesity is a risk factor for breast cancer and is associated with increased plasma concentrations of free fatty acids (FFAs). We and others have demonstrated that FFA induces plasminogen activator inhibitor-1 (PAI-1) expression in a variety of cells. Emerging evidence supports elevation of PAI-1 as a prognostic marker for breast cancer. Therefore, we hypothesized that FFAs might increase expression of PAI-1 in breast cancer cells and facilitate breast cancer progression. Secreted PAI-1 was higher in invasive and metastatic MDA-MB-231 cells compared with less invasive and non-metastatic Hs578T cells. Utilizing FFAs with different saturation and chain lengths, we demonstrated that linoleic acid induced expression of PAI-1 in MDA-MB-231 cells. Linoleic acid also induced in vitro migration of MDA-MB-231. By contrast, other FFAs tested had little or no effect on PAI-1 expression or migration. Linoleic acid-induced breast cancer cell migration was completely inhibited by virally expressed antisense PAI-1 RNA. Furthermore, increased expression of PAI-1 by FFAs was not detected in the SMAD4-deficient MDA-MB-468 breast carcinoma cells. Electrophoretic mobility-shift assay confirmed that linoleic acid-induced expression of PAI-1 was mediated, at least in part, by SMAD4 in MDA-MB-231 cells. That linoleic acid induces PAI-1 expression in breast cancer cells through SMAD4 provides a novel insight into understanding the relationships between two migration-associated molecules, FFAs, and PAI-1. Laboratory Investigation (2009) 89, 1221-1228; doi: 10.1038/labinvest.2009.97; published online 14 September 2009
引用
收藏
页码:1221 / 1228
页数:8
相关论文
共 50 条
  • [41] Plasminogen activator inhibitor-1 4G/5G polymorphism and susceptibility to endometriosis in the Italian population
    Gentilini, Davide
    Vigano, Paola
    Castaldi, Davide
    Mari, Daniela
    Busacca, Mauro
    Vercellini, Paolo
    Somigliana, Edgardo
    di Blasio, Anna Maria
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2009, 146 (02) : 219 - 221
  • [42] Smad4 inhibits cell migration via suppression of JNK activity in human pancreatic carcinoma PANC-1 cells
    Zhang, Xueying
    Cao, Junxia
    Pei, Yujun
    Zhang, Jiyan
    Wang, Qingyang
    ONCOLOGY LETTERS, 2016, 11 (05) : 3465 - 3470
  • [43] Targeting Plasminogen Activator Inhibitor-1 Inhibits Angiogenesis and Tumor Growth in a Human Cancer Xenograft Model
    Gomes-Giacoia, Evan
    Miyake, Makito
    Goodison, Steve
    Rosser, Charles J.
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (12) : 2697 - 2708
  • [44] Plasminogen activator inhibitor-1 4G/5G polymorphism is associated with type 2 diabetes risk
    Zhao, Luqian
    Huang, Ping
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2013, 6 (08): : 632 - 640
  • [45] GATA3 Transcription Factor Abrogates Smad4 Transcription Factor-mediated Fascin Overexpression, Invadopodium Formation, and Breast Cancer Cell Invasion
    Sun, Jianwei
    He, Huifang
    Pillai, Smitha
    Xiong, Yin
    Challa, Sridevi
    Xu, Liyan
    Chellappan, Srikumar
    Yang, Shengyu
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2013, 288 (52) : 36971 - 36982
  • [46] Arterial thrombosis in a newborn with homozygous plasminogen activator inhibitor-1 4G/4G polymorphism
    Sanchez, Luisanna M.
    Snarr, Brian S.
    Soni, Heather
    Lee-Kim, YoungNa
    Cohen, Clay T.
    PEDIATRIC BLOOD & CANCER, 2022, 69 (08)
  • [47] XR5967, a novel modulator of plasminogen activator inhibitor-1 activity, suppresses tumor cell invasion and angiogenesis in vitro
    Brooks, TD
    Wang, SMW
    Brünner, N
    Charlton, PA
    ANTI-CANCER DRUGS, 2004, 15 (01) : 37 - 44
  • [48] Long noncoding RNA MALAT1 promotes cell proliferation through suppressing miR-205 and promoting SMAD4 expression in osteosarcoma
    Li, Qingbo
    Pan, Xiaohan
    Wang, Xiqian
    Jiao, Xiejia
    Zheng, Jiachun
    Li, Zhiqiang
    Huo, Yanqing
    ONCOTARGET, 2017, 8 (63) : 106648 - 106660
  • [49] Elevation of Plasminogen Activator Inhibitor-1 Promotes Differentiation of Cancer Stem-Like Cell State by Hepatitis C Virus Infection
    Nam, Da-eun
    Angelucci, Angelina
    Choi, Dahsom
    Leigh, Arnold
    Seong, Hae Chang
    Hahn, Young S.
    JOURNAL OF VIROLOGY, 2021, 95 (10)
  • [50] SRT1720, a SIRT1 activator, promotes tumor cell migration, and lung metastasis of breast cancer in mice
    Suzuki, Kensuke
    Hayashi, Ryuji
    Ichikawa, Tomomi
    Imanishi, Shingo
    Yamada, Toru
    Inomata, Minehiko
    Miwa, Toshiro
    Matsui, Shoko
    Usui, Isao
    Urakaze, Masaharu
    Matsuya, Yuji
    Ogawa, Hirofumi
    Sakurai, Hiroaki
    Saiki, Ikuo
    Tobe, Kazuyuki
    ONCOLOGY REPORTS, 2012, 27 (06) : 1726 - 1732